“LGALS3 +191A and +292C Polymorphisms Are Associated With a Reduction in Serum Gal-3 Levels, But Not With the Clinical Events of Individuals With Sickle Cell Anemia”. Research, Society and Development, vol. 9, no. 9, Aug. 2020, p. e442997314, https://doi.org/10.33448/rsd-v9i9.7314.